Engine Biosciences to raise additional funding next year

Singapore

A BIOTECH startup that only this year raised what is believed to be the largest round of seed funding in South-east Asia has plans to raise additional funding as early as next year, The Business Times has learnt.

Engine Biosciences, a Singapore-based company that has built an artificial intelligence (AI) and genomics network biomedicine platform to enable faster and more effective drug discovery, in January said that it had snagged US$10 million in seed funding, one of the largest rounds in Asia in the tech and biotech industries.